Literature DB >> 1376350

Surface markers, heavy chain sequences and B cell lineages.

H H Wortis1.   

Abstract

A unifying theory of B cell development and lineage commitment is presented. There are two firmly established B lineages: cells which normally arise only from fetal sources and lack N insertions in their rearranged heavy chains; and N-containing cells which arise from adult bone marrow precursors (and perhaps from late fetal sources). Commitment to the expression of CD5 and the capacity for long-life (or self-renewal) are induced as a consequence of sIg cross-linking, typically by a repeating epitope, thymus independent type two antigen. Alternatively, activation resulting from cognate interaction with a helper T cell does not induce CD5 but results in lower expression of J11d. In this case activation occurs in the absence of sIg cross-linking. It is further proposed that differences in the Ig repertoire make it highly likely that fetal/neonatal, but not adult derived B cells will be induced to express CD5. The model offers a plausible explanation for the correlation of CD5 expression and natural autoantibody production by neonatal B cells. Possible sources of pathogenic autoantibody are discussed in the context of this model.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376350     DOI: 10.3109/08830189209055576

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  8 in total

1.  CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40.

Authors:  A Gagro; N McCloskey; A Challa; M Holder; G Grafton; J D Pound; J Gordon
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

2.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

3.  B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development.

Authors:  K P Lam; K Rajewsky
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

4.  B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation.

Authors:  S H Clarke; L W Arnold
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

5.  Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells.

Authors:  N Solvason; W W Wu; N Kabra; F Lund-Johansen; M G Roncarolo; T W Behrens; D A Grillot; G Nunez; E Lees; M Howard
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

6.  Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome.

Authors:  R N Haire; R D Buell; R T Litman; Y Ohta; S M Fu; T Honjo; F Matsuda; M de la Morena; J Carro; R A Good
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

7.  Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression.

Authors:  L W Arnold; C A Pennell; S K McCray; S H Clarke
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

8.  Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.

Authors:  S Hashimoto; M Dono; M Wakai; S L Allen; S M Lichtman; P Schulman; V P Vinciguerra; M Ferrarini; J Silver; N Chiorazzi
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.